Bone Marrow Pathology Predicts Mortality in Chronic Hemodialysis Patients

Table 2

Indications for bone marrow biopsy stratified according to survival status ().

Variable	Total ()	Survivors ()	Nonsurvivors ()	value
Unexplained anemia, (%)	35 (44.9%)	23 (47.9%)	12 (40.0%)	0.021^*
Unexplained leukocytosis and leukopenia, (%)	11 (14.1%)	5 (10.4%)	6 (20.0%)
Fever of unknown origin, (%)	5 (5.1%)	2 (4.2%)	3 (10.0%)
Suspected multiple myeloma, (%)	11 (14.1%)	8 (16.7%)	3 (10.0%)
Suspected lymphoma, (%)	7 (9.0%)	3 (6.3%)	4 (13.3%)
Pancytopenia, (%)	15 (19.2%)	10 (20.8%)	5 (16.7%)
Thrombocytosis, (%)	1 (1.3%)	1 (2.1%)	0 (0.0%)
Thrombocytopenia, (%)	7 (17.9%)	5 (10.4%)	2 (6.7%)
Suspected hemolytic-uremic syndrome, (%)	1 (1.3 %)	1 (2.1%)	0 (0.0%)

^*.